17-Amino-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-ol

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: 17-Amino-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-ol
• 化学式: C₁₈H₂₅NO
• 分子量: 271.4
• InChiKey: VPONVJPFULJPAN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  20
• 可旋转键数：
  0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  46.2
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• [EN] MODULUS MODIFIERS AND FILMS THEREOF<br/>[FR] MODIFICATEURS DE MODULE ET FILMS ASSOCIÉS
  申请人：ZYMERGEN INC

  公开号：WO2022006145A1

  公开（公告）日：2022-01-06

  The present disclosure relates to compositions derived from bioreachable molecules, such as amino acids and/or steroids. In particular, the composition can be a monomer, a polymer, or a copolymer derived from an amino acid dimer. Such compositions can optionally include a functionalized steroid.

  本公开涉及从生物可达分子（如氨基酸和/或类固醇）衍生的组合物。具体来说，该组合物可以是从氨基酸二聚体衍生的单体、聚合物或共聚物。这种组合物可以选择性地包括一个功能化的类固醇。
• Thiadiazole Compounds and Uses Thereof
  申请人：Rajagopalan Raghavan

  公开号：US20090036502A1

  公开（公告）日：2009-02-05

  Thiadiazole compounds, compositions, bioconjugates, and methods for targeting and photoactivation at target sites.

  噻二唑化合物、组成物、生物共轭物和在目标位点进行靶向和光活化的方法。
• COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE AND RELATED DISORDERS
  申请人：Signal Coordinating Therapy, Inc.

  公开号：EP2214488B1

  公开（公告）日：2016-12-21
• Photoactive Compounds and Compositions and Uses Thereof
  申请人：Rajagopalan Raghavan

  公开号：US20090035363A1

  公开（公告）日：2009-02-05

  Photoactive compounds and compositions, as well as methods of using the same. For example, compositions of the invention may be used in Type 1 phototherapy, Type 2 phototherapy, or a combination of Types 1 and 2 phototherapy.
• Pyrazine Derivatives for Bioconjugation
  申请人：Rajagopalan Raghavan

  公开号：US20120134930A1

  公开（公告）日：2012-05-31

  Provided are compounds and compositions of general Formula IX: E1-L-Ar-X-PA, that may be utilized in bioconjugation procedures, where Ar is a chromophore and PA is a functional group capable of being attached to any bioactive molecule of interest. The present invention provides Formulas I-III that are capable of being attached to a bioactive vector for the selective delivery of said photoactive pyrazine derivatives to a desired biological target.